Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

Cited by (332)

Items 301–332 of 332

1. Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
   Eric Ji Da Wang, Arup K. Chakraborty · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
2. Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021
   Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, María T. Herrera-Sepúlveda, Pilar Tavera-Rodríguez, Katherine Laiton‐Donato, Carlos Franco-Muñoz, Héctor Alejandro Ruiz-Moreno, Dioselina Peláez‐Carvajal, Alejandra M. Muñoz-Suarez, Marisol Galindo et al. · 2022 · medRxiv
3. Risk of SARS-CoV-2 Reinfections in Children: Prospective National Surveillance, January 2020 to July 2021, England
   Anna A. Mensah, Helen Campbell, Julia Stowe, Giulia Seghezzo, Ruth Simmons, Joanne Lacy, Antoaneta Bukasa, Shennae O'Boyle, Mary Elizabeth Ramsay, Kevin Edward Brown et al. · 2021 · SSRN Electronic Journal
4. Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 Variants
   Shumin Liao, Yunjiao He, Jing Tao Qu, Yue Shi, Yingzi Liu, Keli Zhao, Junhui Chen, Jing Yue, Clifton Kwang-Fu Shen, Chong Ji et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
5. Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis
   R. Elias Alvarado, Jennifer Chen, Kumari G. Lokugamage, Yiyang Zhou, Leah K. Estes, Angelica L. Morgan, Yani P. Ahearn, Xiangxue Deng, Lilin Lai, Arian Moayyed et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
6. Current and Prospective Therapeutic Regimens for SARS-CoV-2: Review on Modern Medicine and Alternate Therapies
   Shalitha Sasi, Sindhu Gopinathan Pillai, Sapna Singh, Ritu Singhal, Lokender Kumar, Imran Khan, Aarti Yadav, Priyanka Bharadwaj, Prabhakar M, Sushil Mehta et al. · 2021 · ACTA SCIENTIFIC MICROBIOLOGY
7. Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent Vaccines
   Evan J. Anderson, Lisa A. Jackson, Nadine Rouphael, Alicia T. Widge, David C. Montefiori, Nicole A. Doria‐Rose, Mehul S. Suthar, Kristen W. Cohen, Sarah E. O’Connell, Mat Makowski et al. · 2022 · Research Square
8. Human Vaccines & Immunotherapeutics: News
   2021 · Human Vaccines & Immunotherapeutics
9. The first confirmed SARS-CoV-2 delta variant in Serbia
   Valentina Opančina, Jorge Bohoyo, Christina Perez, Ana Todorović, Miljan Opančina, Ruzica Radojevic Marjanovic, Radisa H. Vojinovic · 2021 · Medicinski casopis
10. Neutralizing Antibody to Omicron BA.1, BA.2 and BA.5 in COVID-19 Patients
    Susanne L. Linderman, Lilin Lai, Estefany Lucia Bocangel Gamarra, Nicholas M. Mohr, Kevin W. Gibbs, Jay S. Steingrub, Matthew C. Exline, Nathan Ivan Shapiro, Anne E. P. Frosch, Nida Qadir et al. · 2022 · medRxiv
11. Latest in COVID-19 Vaccine 'Candidates' Race
    Manar Fayiz Mousa Atoum, Dalia Abu Zreig, Laith Majed Abu Zreig · 2022 · Infectious Disorders - Drug Targets
12. Antibody avidity and multi-specificity combined to confer protection against SARS-CoV-2 and resilience against viral escape
    Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, Hong Cui, Katherine Prieto, Manoj S. Nair, Maple Wang, Yaoxing Huang, Natasha Christie-Holmes, Betty Poon et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
13. Safeguarding Against the Analog of Antimicrobial-Resistance Development
    Siguna Mueller · 2022 · Springer eBooks
14. Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections
    Maryam I. Azeem, Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee V. Potdar, Renee Julia Manalo, Alberto Moreno, Jeffrey M. Switchenko, Suneethamma Cheedarla, Deon Bryant Doxie et al. · 2023
15. The Systematic Research of The Comparison of Moderna Covid-19 Vaccine and Pfizer Covid-19 Vaccine
    Qiming Wang · 2023 · Highlights in Science Engineering and Technology
16. Coronavirus Vaccines
    Stanley M. Perlman, Mark R. Denison · 2023 · Elsevier eBooks
17. "Cross-Reactivity of Neutralizing Antibodies Against SARS-CoV-2 in Patients Infected by Various Clades (S, L, V, GR, G, GH and GV)"
    Eun‐Jin Kim · 2023 · Biomedical Journal of Scientific & Technical Research
18. Immunogenicity and protective efficacy of an influenza virus-like particle-based SARS-CoV-2 hybrid vaccine candidate in rhesus macaques
    Sheikh Abdul Rahman, Ramireddy Bommireddy, Nanda Kishore Routhu, Lilin Lai, Christopher D. Pack, Sampath Ramachandiran, Mehul S. Suthar, Shaker J. C. Reddy, Periasamy Selvaraj, Rama Rao Amara · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
19. The Study of the COVID-19 Virus: A Review
    Marika L. Forsythe · 2024 · The Open COVID Journal
20. Strategies to determine positive anti-SARS-CoV-2 memory T lymphocyte response during the evolution of an epidemic
    Isabelle Nel, Ajeeva Ithayakumar, Noémie Blumenthal, Charlotte Duneton, Valérie Guérin, Jérôme Viala, Catherine Dollfus, Véronique Baudouin, Sophie Guilmin‐Crépon, Ioannis D Theodorou et al. · 2024 · Journal of Immunological Methods
21. Differential epitope prediction across diverse circulating variants of SARS-COV-2 in Brazil
    Vanessa de Melo Cavalcanti-Dantas, Brenda Fernandes, Pedro Henrique Lopes Ferreira Dantas, Glaucielle Ramalho Uchoa, Andrei Félix Mendes, Waldecir Oliveira de Araújo Júnior, Lúcio Roberto Cançado Castellano, Ana Isabel Vieira Fernandes, Luíz Ricardo Goulart, Renato Antônio dos Santos Oliveira et al. · 2024 · Computational Biology and Chemistry
22. Additional file 1 of Community transmission of SARS-CoV-2 during the Delta wave in New York City
    Katherine Dai, Steffen Foerster, Vora, Neil M., Kathleen Blaney, Chris Keeley, Hendricks, Lisa, Jay K. Varma, Theodore G. Long, Jeffrey L. Shaman, Pei, Sen · 2023 · Figshare
23. Additional file 1 of The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
    Xiru Zhang, Zhiju Li, Fu, Qi, Wang, Jin-Dong, Qingmei Huang, Song, Wei-Qi, Xu, Xiao-Yu, Zhihao Li, Mao, Chen · 2023 · Figshare
24. Additional file 1 of Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
    Harini Natarajan, Shiwei Xu, Andrew R. Crowley, Savannah E. Butler, Joshua A. Weiner, Evan M. Bloch, Littlefield, Kirsten, Sarah E. Benner, Ruchee Shrestha, Olivia Ajayi et al. · 2022 · Figshare
25. Additional file 1 of Reinfection in patients with COVID-19: a systematic review
    Ren, Xiangying, Zhou, Jie, Guo, Jing, Chunmei Hao, Mengxue Zheng, Zhang, Rong, Huang, Qiao, Yao, Xiaomei, Li, Ruiling, Jin, Yinghui · 2022 · Figshare
26. Bases moléculaire de l'interaction protéine-protéine lors de la synaptogenèse
    Emma Goulard Coderc de Lacam · 2023 · theses.fr (ABES)
27. Modeling and Standard Binding Free Energy Calculations of Complex Biological Objects
    Marharyta Blazhynska · 2023 · theses.fr (ABES)
28. Biographical Feature: Benjamin A. Pinsky, MD, PhD
    Erik Munson · 2026 · Journal of Clinical Microbiology
29. Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans
    Beatriz Praena, Frances K. Shepherd, Cera A. McDonald, Devyani Joshi, Sneh Lata Gupta, Madison L Ellis, Lilin Lai, Alberto Moreno, Shanley N. Roach, Mark J. Pierson et al. · 2026 · mBio
30. Antagonism of stress granules is key to SARS-CoV-2 infection and pathogenesis
    R. Elias Alvarado, Jennifer Chen, Kumari G. Lokugamage, Yiyang Zhou, Leah K. Estes, Angelica L. Morgan, Yani P. Ahearn, Xiangxue Deng, Lilin Lai, Arian Moayyed et al. · 2026 · Journal of Virology
31. Characterization of SARS-CoV-2 Spike mutations
    Michael Schotsaert · 2025 · ImmPort
32. BindingDB Entry 50022184: Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2.
    BindingDB · 2025 · UC San Diego